Effects of echo time variation on perfusion assessment using dynamic susceptibility contrast MR imaging at 3 tesla.
The implications of changing the echo time of a gradient-echo echo planar imaging sequence applied to dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) for perfusion imaging at 3T were investigated. Four echo times in the range of 21 to 45 ms were examined in a total of 17 patients who received a dose of 0.1 mmol/kg bodyweight Gadobutrol (Gadovist, 1.0 mmol/ml). As the primary optimization parameter, the concentration-to-noise ratio (SNRc) was selected as it takes effects of variations in baseline as well as in signal drop into account. In an analysis of gray matter, white matter and arterial regions of interest, SNRc showed the highest values for the shortest applied echo time in all cases. Maps of regional cerebral blood volume (rCBV) and blood flow (rCBF) were calculated using deconvolution based on singular value decomposition. The quality of rCBF and rCBV images was judged to be good or excellent in all cases, independent of the echo time. Calculated gray matter/white matter ratios of rCBF and rCBV displayed no significant dependence on the applied echo time. Considering the better SNRc and arterial signal saturation aspects, we found that the shortest investigated echo time was the superior one. We thus suggest that short echo times should be applied, taking technical limitations and clinical demands into consideration.
Thilmann
O
O
Department of Medical Radiation Physics, Lund University, Sweden. oliver.thilmann@radfys.lu.se
Larsson
E-M
EM
Björkman-Burtscher
I M
IM
Ståhlberg
F
F
Wirestam
R
R
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001783:Blood Flow Velocity / Q000502:physiology; D001921:Brain / Q000033:anatomy & histology / Q000098:blood supply*; D001931:Brain Mapping / Q000379:methods; D002560:Cerebrovascular Circulation; D003287:Contrast Media / Q000008:administration & dosage; D017352:Echo-Planar Imaging / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds / Q000008:administration & dosage; D012039:Regional Blood Flow / Q000502:physiology; D018709:Statistics, Nonparametric
D003287:Contrast Media; D009942:Organometallic Compounds; C090600:gadobutrol